ReviewACS omega2021
Controllable Synthesis of Bimetallic Nanostructures Using Biogenic Reagents: A Green Perspective.
Review in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Green Nanoparticles for Enhanced Electrochemical Monitoring of Pharmaceutical Contaminants: Comparative Investigation Between Monometallic and Bimetallic Nanoparticles.Micromachines · 2025Article
- Bimetallic Gold--Platinum (AuPt) Nanozymes: Recent Advances in Synthesis and Applications for Food Safety Monitoring.Foods (Basel, Switzerland) · 2025Review
- Spectroscopic approach to optimize the biogenic silver nanoparticles for photocatalytic removal of ternary dye mixture and ecotoxicological impact of treated wastewater.Scientific reports · 2024Article
- Article
- Understanding the Stability of an Unprecedented Si-Be Bond within Quantum Confinement.ACS omega · 2023Article
- Article
- State of the Art on Green Route Synthesis of Gold/Silver Bimetallic Nanoparticles.Molecules (Basel, Switzerland) · 2022Review
- Au@Ag Core@Shell Nanoparticles Synthesized with Rumex hymenosepalus as Antimicrobial Agent.Nanoscale research letters · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bimetallic nanostructures are emerging as a significant class of metal nanomaterials due to their exceptional properties that are useful in various areas of science and technology. When used for catalysis and sensing applications, bimetallic nanostructures have been noted to exhibit better performance relative to their monometallic counterparts owing to synergistic effects. Furthermore, their dual metal composition and configuration can be modulated to achieve optimal activity for the desired functions. However, as with other nanostructured metals, bimetallic nanostructures are usually prepared through wet chemical routes that involve the use of harsh reducing agents and hazardous stabilizing agents. In response to intensifying concerns over the toxicity of chemicals used in nanomaterial synthesis, the scientific community has increasingly turned its attention toward environmentally and biologically compatible reagents that can enable green and sustainable nanofabrication processes. This article aims to provide an evaluation of the green synthetic methods of constructing bimetallic nanostructures, with emphasis on the use of biogenic resources (e.g., plant extracts, DNA, proteins) as safe and practical reagents. Special attention is devoted to biogenic synthetic protocols that demonstrate controllable nanoscale features, such as size, composition, morphology, and configuration. The potential use of these biogenically prepared bimetallic nanostructures as catalysts and sensors is also discussed. It is hoped that this article will serve as a valuable reference on bimetallic nanostructures and will help fuel new ideas for the development of more eco-friendly strategies for the controllable synthesis of various types of nanostructured bimetallic systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.